A comparison of the ability of the National Early Warning Score and the National Early Warning Score 2 to identify patients at risk of in-hospital mortality: a multi-centre database study by Pimentel, Marco A.F. et al.
Accepted Manuscript
Title: A comparison of the ability of the National Early
Warning Score and the National Early Warning Score 2 to
identify patients at risk of in-hospital mortality: a multi-centre
database study
Authors: Marco A.F. Pimentel, Oliver C. Redfern, Stephen
Gerry, Gary S. Collins, James Malycha, David Prytherch, Paul
E. Schmidt, Gary B. Smith, Peter J. Watkinson
PII: S0300-9572(18)30945-6
DOI: https://doi.org/10.1016/j.resuscitation.2018.09.026
Reference: RESUS 7765
To appear in: Resuscitation
Received date: 15-6-2018
Revised date: 26-9-2018
Accepted date: 28-9-2018
Please cite this article as: Pimentel MAF, Redfern OC, Gerry S, Collins GS, Malycha
J, Prytherch D, Schmidt PE, Smith GB, Watkinson PJ, A comparison of the ability of
the National Early Warning Score and the National Early Warning Score 2 to identify
patients at risk of in-hospital mortality: a multi-centre database study, Resuscitation
(2018), https://doi.org/10.1016/j.resuscitation.2018.09.026
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
A comparison of the ability of the National Early Warning Score and 
the National Early Warning Score 2 to identify patients at risk of in-
hospital mortality: a multi-centre database study. 
 
 
Marco AF Pimentel, Oliver C Redfern, Stephen Gerry, Gary S Collins, James Malycha, David 
Prytherch, Paul E Schmidt, Gary B Smith, Peter J Watkinson,  
 
 
Marco AF Pimentel, Postdoctoral Researcher, Institute of Biomedical Engineering, Department of 
Engineering Science, University of Oxford, Oxford, UK 
Oliver C Redfern, Research Fellow, Centre for Healthcare Modelling and Informatics, University of 
Portsmouth, Portsmouth, UK 
Stephen Gerry, Medical Statistician and NIHR Doctoral Research Fellow, Centre for Statistics in 
Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, 
Botnar Research Centre, University of Oxford, Oxford, UK 
Gary S Collins, Professor of Medical Statistics, Centre for Statistics in Medicine, Nuffield Department 
of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of 
Oxford, Oxford, UK 
James Malycha, Clinical Research Fellow, Nuffield Department of Clinical Neurosciences, Oxford 
University Hospitals NHS Trust, Oxford, UK 
David Prytherch, Professor of Health Informatics, Centre for Healthcare Modelling and Informatics, 
University of Portsmouth, Portsmouth, UK 
Paul E Schmidt, Consultant Physician in Acute Medicine, Portsmouth Hospitals NHS Trust, 
Portsmouth, UK 
Gary B Smith, Professor, Faculty of Health and Social Sciences, Bournemouth University, 
Bournemouth, UK 
Peter J Watkinson, Associate Professor of Intensive Care Medicine, Nuffield Department of Clinical 
Neurosciences, Oxford University Hospitals NHS Trust, Oxford, UK 
 
*Correspondence to: 
Marco AF Pimentel, 
Postdoctoral Researcher, 
Institute of Biomedical Engineering, 
Department of Engineering Science, 
University of Oxford, 
Oxford 
AC
CE
PT
ED
 M
AN
US
CR
IPT
2 
 
UK 
Email: marco.pimentel@eng.ox.ac.uk 
 
 
ABSTRACT 
 
Aims: To compare the ability of the National Early Warning Score (NEWS) and the National Early 
Warning Score 2 (NEWS2) to identify patients at risk of in-hospital mortality and other adverse 
outcomes. 
Methods: We undertook a multi-centre retrospective observational study at five acute hospitals 
from two UK NHS Trusts. Data were obtained from completed adult admissions who were not fit 
enough to be discharged alive on the day of admission. Diagnostic coding and oxygen prescriptions 
were used to identify patients with type II respiratory failure (T2RF). The primary outcome was in-
hospital mortality within 24 hours of a vital signs observation. Secondary outcomes included 
unanticipated intensive care unit admission or cardiac arrest within 24 hours of a vital signs 
observation. Discrimination was assessed using the c-statistic. 
Results: Among 251,266 adult admissions, 48,898 were identified to be at risk of T2RF by diagnostic 
coding. In this group, NEWS2 showed statistically significant lower discrimination (c-statistic, 95% CI) 
for identifying in-hospital mortality within 24 hours (0.860, 0.857-0.864) than NEWS (0.881, 0.878-
0.884). For 1,394 admissions with documented T2RF, discrimination was similar for both systems: 
NEWS2 (0.841, 0.827-0.855), NEWS (0.862, 0.848-0.875). For all secondary endpoints, NEWS2 
showed no improvements in discrimination.   
Conclusions: NEWS2 modifications to NEWS do not improve discrimination of adverse outcomes in 
patients with documented T2RF and decrease discrimination in patients at risk of T2RF. Further 
evaluation of the relationship between SpO2 values, oxygen therapy and risk should be investigated 
further before wide-scale adoption of NEWS2. 
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INTRODUCTION 
 
 
Vital signs based aggregate early warning score (EWS) systems, which assign weights to each vital 
sign according to the deviation from assumed normal values, are recommended for routine use in 
UK hospitals [1, 2]. In 2012, the Royal College of Physicians of London (RCPL) published a proposed 
National EWS (NEWS) [3], which has now undergone extensive validation [4–6]. In NEWS, oxygen 
saturations (SpO2) receive increasing weights for values of 95% or less, and oxygen therapy receives 
a flat weight. However, guidance for the management of patients with type II respiratory failure 
(T2RF) [7, 8], and those deemed at risk of T2RF before blood gas analysis [7], suggests lower SpO2 
values (88-92%) should be targeted. Consequently, it is suggested that the NEWS SpO2 weighting 
system is inappropriate for patients with/at risk of T2RF [9–11]. Some authors suggest that this 
weighting risks inappropriate oxygen therapy for these patients, with potential deleterious 
consequences [9, 10].  
In December 2017, the RCPL published an update to NEWS - the National Early Warning Score 2 
(NEWS2) [12] - which includes several modifications to the NEWS vital sign weightings. To account 
for concerns about NEWS and T2RF, NEWS2 includes a new SpO2 scoring scale for patients with/at 
risk of T2RF. This scale, termed SpO2 scale 2 assigns weights at lower SpO2 thresholds than NEWS 
and combines these lower thresholds with weights for the use of supplemental oxygen at higher 
SpO2 levels, reflecting the concern of hyperoxia-induced hypercapnic respiratory failure [12] (see 
appendix A1). Although the derivation of these thresholds is not presented, and NEWS2 is as yet 
unvalidated, NHS England has endorsed NEWS2’s use in acute and ambulance settings [13], and is 
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considering the use of the Commissioning for Quality and Innovation (CQUIN) payment system [14, 
15] to encourage organisations to implement NEWS2 by March 2019. 
In this study, we used a large multi-centre dataset of vital signs to compare retrospectively the 
performance of NEWS2 and NEWS. We studied the performance of NEWS and NEWS2 in three risk 
groups: those with documented T2RF; those at risk of T2RF; and patients in neither of these groups. 
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METHODS 
The database for this study was created with Health Research Authority (reference: 16/SC/0264 and 
08/02/1394) approval. The study protocol is available online [16]; we follow the TRIPOD statement 
for reporting [17].   
Source of data 
A database of vital sign observations was collated from adult (aged at least 16 years) acute 
admissions to the Oxford University Hospitals (OUH) group and Portsmouth Hospitals NHS Trust (PH) 
as part of the Hospital Alerting Via Electronic Noticeboard (HAVEN) dataset [18]. Clinical staff 
recorded patients’ vital signs at the bedside using the System for Electronic Notification and 
Documentation (SEND, Drayson Technologies, www.draysontechnologies.com) [19] in OUH and 
VitalPACTM (System C Healthcare, www.systemc.com) in PH [20]. The following data were recorded: 
date and time of observation (automatically by SEND/VitalPACTM); heart rate, systolic blood 
pressure, respiratory rate, body temperature, neurological status using the Alert-Voice-Pain-
Unresponsive (AVPU) scale, SpO2; and the patient’s inspired gas (air or supplemental oxygen) at the 
time of SpO2 measurement. The HAVEN database also contains administrative and patient 
demographic information, and information about the occurrence and timing of cardiac arrest, 
unanticipated intensive care unit (ICU) admission and hospital discharge status (dead/alive) for 
included patients. Prescription data from the electronic patient record is also available within the 
database for OUH admissions.  
Study sites 
The study took place at five hospitals – the four hospitals in the OUH group [The John Radcliffe 
Hospital (large university hospital), The Horton General Hospital (small district general hospital), The 
Churchill hospital (large university cancer centre) and The Nuffield Orthopaedic Hospital] and a 
single large district general hospital, PH. 
Participants  
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All completed adult admissions to the four hospitals comprising the OUH group (January-December 
2016) and to PH (January 2012 - December 2016) with at least one complete set of vital signs 
observations recorded electronically were considered. These study periods represent times of full 
deployment of electronic vital signs documentation in these hospitals. Patients discharged alive from 
the hospital before midnight on the day of admission and those with no vital signs recorded in the 24 
hours prior to discharge (as a proxy for patients on end-of-life pathways) were excluded from the 
analysis. For the main analysis, we combined admissions from all hospitals, but we also analysed 
data from each hospital trust separately (see appendix A3).   
Early Warning Scores (see appendix A1). 
The NEWS2 adjustment for patients with/at risk of T2RF differs from NEWS in the assignment of 
weights to measured SpO2 (NEWS weights SpO2 values below 96%; NEWS2 below 88%). Additionally, 
for patients with/at risk of T2RF, NEWS2 assigns weights for SpO2 values above 92% when receiving 
oxygen.  
Outcome 
The primary outcome was in-hospital death within 24 hours of an observation set, in line with 
previous studies [21, 22]. Secondary outcomes include cardiac arrest, unanticipated ICU admission, 
and either cardiac arrest, unanticipated ICU admission, or death within 24 hours of an observation 
set. We present the results for all secondary outcomes, flagging those where insufficient outcomes 
exist (< 100), due to sample size, as recommended in the TRIPOD guidelines [17]. All outcomes were 
obtained retrospectively from different clinical information systems, including the hospitals’ patient 
administration systems, the ICU clinical information systems, and the hospitals’ National Cardiac 
Arrest Audit (https://ncaa.icnarc.org) databases. 
Predictors 
Vital sign sets (see above) were recorded using SEND/VitalPACTM. Where the patient’s conscious 
level had been assessed only using the Glasgow Coma Scale (GCS), we converted GCS to an AVPU 
equivalent [21]. Vital signs were then assigned weights for NEWS and NEWS2 scores (see appendix 
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A1). The sum of the weights (aggregate score) results in the NEWS and NEWS2 value for each 
observation set. SEND (OUH) uses a modified EWS, CEWS [23], which assigns increasing weights to 
SpO2 values less than 94% and does not weight SpO2 values of 94% or above. Clinical staff entering 
vital signs data were therefore unaware of NEWS or NEWS2 scores. VitalPACTM (PH) uses NEWS. To 
allow comparison with published analyses of NEWS [22, 24], and in line with previous vital-signs-
based EWS research [25–28], each vital sign set was analysed as independently associated with the 
outcome. 
Missing data 
For the analysis, we considered complete observation sets (i.e., sets with measurements of all vital 
signs), in line with previous NEWS studies [22, 24]. The SEND system allows recording of incomplete 
vital sign sets, which is discouraged in the VitalPACTM system. We did an a priori sub-analysis in 
which we used multiple imputation, a general-purpose and widely used approach to missing values 
[29] which only occurred in the OUH dataset.  
Statistical analysis 
Performance of NEWS and NEWS2 was assessed by discrimination (calibration was not assessed, as 
the EWS systems do not give estimates of absolute risk). We also assessed the effect of suggested 
thresholds for patient review (aggregate NEWS/NEWS2 scores of 5 or above, or 7 or above [12]) by 
reporting sensitivity, specificity and positive predictive values. We also show SpO2 distributions for 
three different risk groups (see below). All analysis was performed using the R statistical software 
(v3.4.4) [30] and ROC curves were calculated using the pROC package [31]. Differences in AUROC 
between NEWS and NEWS2 were compared using bootstrapping (2000 samples) [31]. We did post-
hoc sub-analyses of performance by institution (in light of the different patient numbers 
contributed). We also performed post-hoc efficiency curve analysis (as we were unable to conduct 
decision curve analysis as estimates of risk for a given score are not available). 
Risk groups 
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After exclusion criteria were applied, we categorised each admission according to the following risk 
groups: 
1.       Patients with recorded T2RF, identified using the Adult Oxygen Prescription form of the 
current admission (OUH only). 
2.       Patients at risk of T2RF, identified using the International Statistical Classification of 
Diseases and Related Health Problems-10 (ICD-10) classification for their concurrent or prior 
admission, with either of the following groups of diagnosis codes: 
2.1.    J40-J44 (typically, 88% coded as J44) - patients with Chronic Obstructive Pulmonary 
Disease (COPD); or 
2.2.    J47 – patients with Bronchiectasis; or 
2.3.    E84 – patients with Cystic Fibrosis; or 
2.4.    E66 – patients with obesity and/or obesity hypoventilation syndrome; or 
2.5.    G12, G47.3, G70-G71, M95.4, or Q67.8, with J96 – patients with respiratory failure 
(J96) and one of the following conditions: spinal muscular atrophy and other motor 
neuron disease (G12), sleep apnoea (G47.3), myasthenia gravis and other myoneural 
disorders (G70), muscular dystrophies (G71), acquired deformity of chest and rib 
(M95.4), or other congenital deformities of chest (Q67.8). 
3.       Patients not at risk of T2RF, i.e., not in groups 1 or 2 above. 
We report the performance metrics of each scoring system for each of these risk groups. We report 
the results of the SpO2 scale 2 of NEWS2 in the third risk group (patients not at risk of T2RF) to 
demonstrate the effect of erroneous use of the scale in this population.    
Development versus evaluation datasets 
NEWS was originally developed using a dataset with admissions to PH’s Medical Assessment Unit 
(MAU) [22].  The NEWS2 report does not identify a development dataset for NEWS2 [12]. The study 
evaluation database (HAVEN) includes data from all admissions to OUH and PH for the periods 
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stated above. Vital sign data for all sites are present from hospital admission to hospital 
discharge/death. NEWS2 is recommended for use in all the included settings. 
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RESULTS 
Descriptive statistics 
A total of 251,266 distinct admissions were included. Figure 1 shows the application of inclusion and 
exclusion criteria, resulting in the final cohort of admissions. All patients in the final dataset had at 
least one complete vital sign set. A total of 48,898 admissions were associated with patients at risk 
of T2RF, and 1,394 with patients with documented T2RF (80.3% of whom also belong to the group of 
patients at risk of T2RF). Table 1 summarises the admission demographic descriptors and other 
clinical information for the three risk groups. Patients in risk groups 1 (documented T2RF) and 2 (at 
risk of T2RF) both had higher mortality rates (and rates of other adverse outcomes) when compared 
to patients who were not at risk (i.e., risk group 3).   
The distribution of SpO2 values for patients with documented T2RF is bell-shaped, whereas that for 
the group of patients who are not at risk was right skewed (figure 2). In patients with documented 
T2RF, 77.4% of admissions had at least one recorded SpO2 measurement above 92% on room air, 
compared with 98.7% in the non-risk group.  
Performance of early warning scores 
Performance metrics for the three risk groups for in-hospital death are presented in table 2. Those 
for the secondary outcomes are shown in table 3. 
Results of the sub-analyses by institution are shown in appendix A3. The effects of using multiple 
imputation to replace missing vital sign values are shown in appendix A4. 
In patients with documented T2RF, the AUROCs for predicting inpatient mortality within 24 hours for 
the two scoring systems were as follows: NEWS 0.862 (95% CI: 0.848 to 0.875); NEWS2 0.841 (0.827 
to 0.855) (table 2). Using a threshold of 5 points, positive predictive values for NEWS and NEWS2 
were 2.5% and 3.0% respectively. In patients at risk of T2RF, the AUROC for predicting inpatient 
mortality within 24 hours for the two scoring systems were as follows: NEWS 0.881 (0.878 to 0.884); 
NEWS2 0.860 (0.857 to 0.864). Using a threshold of 5 points, positive predictive values for NEWS and 
NEWS2 were 3.2% and 2.7%, respectively. 
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Our sub-analysis using multiple imputation to deal with missing values gave similar results (appendix 
A4). 
We used efficiency curves (see appendix A2) to compare the efficiency of NEWS and NEWS2. The 
curves demonstrate that, for the few patients with documented T2RF, the use of NEWS2 at the 
suggested RCPL cut-offs of 5 and 7 points [12] reduces absolute staff workload by approximately 
11% and 5% respectively, but at the expense of reduced sensitivity of approximately 10% and 14%, 
respectively. For patients at risk of T2RF, the use of NEWS2 at the suggested RCPL cut-offs of 5 and 7 
points [13] does not significantly decrease staff workload, but reduces sensitivity by 5-6%. Finally, if 
used in error for patients not at risk of T2RF at the suggested RCPL cut-offs, NEWS2 is slightly more 
sensitive than NEWS but, to achieve this, risks doubling the workload. 
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DISCUSSION 
Main findings 
This is the first study to evaluate the performance of NEWS2 in hospitalised patients who have 
documented T2RF or are at risk of it. For the primary outcome - in-hospital death within 24 hours of 
an observation – NEWS2 demonstrated no improvement in discrimination over NEWS for patients 
with documented T2RF, but at the suggested RCPL cut-offs of 5 and 7 points, the positive predictive 
values (PPV) were higher for NEWS2 than NEWS. However, for patients at risk of T2RF, NEWS had 
superior discrimination and higher PPV compared to NEWS2. When applied to patients not at risk of 
T2RF (to simulate the impact of using NEWS2 in error in such patients) NEWS2 discriminated less 
well than NEWS and had lower PPV. Finally, NEWS2 did not improve discrimination for any of the 
secondary outcomes compared to NEWS.   
Modified scores have been suggested to account for chronically altered physiology in patients with 
respiratory-related conditions [10–12]. One of these, CREWS [11], improved the positive predictive 
value compared to NEWS in patients with or at risk of T2RF (see appendix), but at the expense of 
decreasing sensitivity for events. However, such approaches contest the premise that a universal 
EWS, with its attendant advantages, should be employed throughout hospitals. In NEWS2, assigning 
lower SpO2 thresholds together with heuristic weights for the use of supplemental oxygen at higher 
SpO2 values reflects the concern of hyperoxia-induced hypercapnic respiratory failure. However, 
encoding this concern as undertaken in NEWS2 does not improve discrimination in any of the three 
risk groups of admissions. Given the main purpose of EWS systems is to identify ill or deteriorating 
patients, the reduced sensitivity introduced by NEWS2 in patients with documented T2RF and those 
at risk of it is a disadvantage compared to NEWS. This reduced sensitivity could be ameliorated to an 
extent by reducing the trigger values for NEWS2, but this would increase staff workload, whilst also 
introducing further unnecessary complexity.   
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The performance of NEWS in this study is similar to that of the original derivation study for NEWS 
(AUROC, 0.89) [22] supporting previous external evaluations of the scoring system [32, 33] (see 
appendix A3, which describes the results considering admissions to each trust, separately).   
Strengths 
This study focuses on the patient groups for which the new SpO2 scoring “scale” in NEWS2 were 
intended. Robust electronic data capture allowed us to identify groups of patients admitted with/at 
risk of T2RF; this has not previously been undertaken. Unlike previous studies [32], our study 
includes vital signs taken throughout the patient’s hospital journey. The additional analyses, and the 
TRIPOD statement that guides our work further strengthen the findings of our study, promoting both 
clarity and interpretability. 
Limitations 
Our study relies on diagnostic codes and records of oxygen prescription to categorise patients 
with/at risk of T2RF, so patients could have been missed or misclassified. However, diagnostic coding 
for COPD has been shown to be relatively reliable [34], suggesting using this approach to identify 
those at risk of T2RF may also be reliable. In the case of oxygen prescriptions, the prescribing 
clinician’s assessment of whether or not the patient is a “carbon dioxide retainer” is recorded, and it 
seems likely that the same assessment would underlie the choice of SpO2 scale used. Our database 
does not include documentation of “new confusion”, which is now recommended to be part of the 
assessment of consciousness on for NEWS2 [12]; hence, we could not take account of this in our 
analysis. Nevertheless, as new confusion was not part of NEWS, our study clearly demonstrates the 
effect of the differences in oxygen SpO2 scales between the two systems for patients with T2RF. 
Moreover, the absence of this component is unlikely to have a different effect in the risk groups. By 
analysing each vital sign set as independently associated with outcome (allowing comparison with 
previous NEWS publications [22, 24]) we run the risk of over-representation of some patient groups. 
However, previous work [35] suggests allowing an outcome to be represented only once has little 
effect on assessed outcomes. Evaluation of the secondary outcomes (cardiac arrest and 
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unanticipated ICU admission) in the documented T2RF group should be interpreted with caution 
given the small number of outcomes (<100). 
Implications 
We could find no performance benefit of NEWS2 in any diagnostic group in comparison to NEWS. If 
used in error in patients not at risk of T2RF, NEWS2 generally reduces discrimination compared to 
NEWS. Using NEWS2 instead of NEWS for patients with or at risk of T2RF reduces sensitivity for 
detecting patients with adverse outcomes. Improving sensitivity could be achieved by reducing the 
trigger values for NEWS2, but this would also increase staff workload. 
The recent endorsement by the RCPL and NHS England of the use of NEWS2 without underpinning 
evidence makes our study both important and urgent. Implementing NEWS2 requires additional 
staff training, and new multi-coloured charts, both of which are likely to be costly. The clinical impact 
of introducing NEWS2 may also have unexpected clinical consequences, some of which may also 
have financial impact.  
Applying the same “normal range” to patients with chronically abnormal physiology (e.g. COPD or 
heart failure) is a compelling criticism of using a single early warning score (EWS). It is certainly at 
odds with the interpretation of individual vital signs in clinical practice. However, this possible 
advantage needs to be counter-balanced with the simplicity of a single system. Applying different 
scores also creates a more complex protocol and observation chart, potentially increasing staff 
workload [36, 37]. Ultimately, increasing score complexity has to be shown to improve performance 
for it to be worthwhile. 
Our study shows that the modifications made to NEWS2 (specifically, the alternative SpO2 scale), 
which increase chart complexity, are not likely to improve the detection of deterioration and/or 
reduce false alarms in patients with chronic respiratory disease.   
CONCLUSION 
For patients at risk of, or with documented, T2RF, the changes proposed in NEWS2 do not improve 
the detection of adverse outcomes, including in-hospital death, unanticipated ICU admission, and 
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cardiac arrest. The intent to account for known physiological differences in patients with chronic 
respiratory failure is laudable, as are the recommended improvements in the chart for recording 
oxygen prescriptions. However, the relationship between SpO2 values, oxygen therapy and the risk 
of adverse outcomes should be studied further before wide-scale adoption of NEWS2. In the interim, 
a more appropriate alternative to changing the weighting system for NEWS, might be to modify the 
clinical care escalation protocol and response to triggering [38].  
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FIGURE LEGENDS 
 
Figure 1. Flowchart showing application of exclusion criteria for obtaining the admissions 
included in the analysis. 
 
Figure 2. Representation of the normalised histograms of oxygen saturation (SpO2) recorded 
for each of the risk groups. For each bar, the relative proportion of measurements performed 
while patients were on oxygen (O2) or on air is shown. 
 
Figure 3. Receiver operating characteristic (ROC) curve for NEWS and  NEWS2 (with scale2), 
for discriminating vital signs observations followed by in-hospital death within the following 24 
hours for the three risk groups (from top to bottom):  admissions with documented type II 
respiratory failure (T2RF), admissions at risk of T2RF, and admissions not at risk of T2RF. 
Sensitivity and 1–Specificity are shown in %.  
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Figr-2 
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TABLE 1 
 Documented 
T2RF 
At risk T2RF 
Not at risk T2RF 
All 
Number of admissions 1,394 48,898 202,094 251,266 
Males,  
N (%) 
696 (49.9) 23,569 (48.2) 95,736 (47.4) 119,433 (47.5) 
Age (years),  
median (IQR) 
75 (67-83) 72 (60-80) 66 (47-80) 68 (50-80) 
Length of stay (days),          
median (IQR) 
6.7 (3.1-14) 4.0 (1.8-9) 2.8 (1.3-6.8) 3.0 (1.3-7.1) 
Charlson Comorbidity Index*, 
median (IQR) 
7 (4-16) 4 (0-14) 0 (0-8) 0 (0-10) 
Elective admissions*, N (%) 104 (7.5) 9351 (19.1) 49978 (24.7) 59374 (23.6) 
Surgical admissions*, N (%) 229 (16.4) 14833 (30.3) 89427 (44.3) 104338 (41.5) 
Ethnic category, N (%)     
    Asian or Asian British 23 (1.6) 281 (0.6) 1850 (0.9) 2136 (0.9) 
    Black or Black British 1 (0.1) 116 (0.2) 1031 (0.5) 1147 (0.5) 
    Mixed 9 (0.6) 117 (0.2) 710 (0.4) 828 (0.3) 
    Other Ethnic Groups 126 (9.0) 4317 (8.8) 29585 (14.6) 33936 (13.5) 
    Not disclosed 5 (0.4) 142 (0.3) 957 (0.5) 1102 (0.4) 
    White 1230 (88.2) 43925 (89.8) 167961 (83.1) 212117 (84.4) 
Primary outcome, N (%)     
    In-hospital mortality 159 (11.4) 2,220 (4.5) 4,606 (2.3) 6,871 (2.7) 
Secondary outcome, N (%)     
    Unanticipated ICU admission 45 (3.2) 575 (1.2) 1,704 (0.8) 2,289 (0.9) 
    Cardiac arrest 18 (1.3) 288 (0.6) 628 (0.3) 920 (0.4) 
Number of vital sign sets 61,340 1,466,420 4,751,323 6,229,740 
 
Table 1. Demographic descriptors for admissions included in each risk group. T2RF denotes Type II 
Respiratory Failure. *The Charlson Comorbidity Index, and definitions of surgical specialties and 
elective admissions were determined according to the methodology and specification provided by 
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NHS Digital (Charlson Comorbidity Index guidelines are available at 
https://beta.digital.nhs.uk/publications/ci-hub/summary-hospital-level-mortality-indicator-shmi). 
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TABLE 2 
 NEWS NEWS2 NEWS – NEWS2 
Documented T2RF    
AUROC (95% CI) 0.862 (0.848 - 0.875) 0.841 (0.827 - 0.855) 0.021 (0.012 - 0.030)† 
Score ≥ 5 / Score ≥ 7    
    Sensitivity 90.7 / 73.9 80.9 / 60.1  
    Specificity 57.8 / 88.8 68.8 / 87.3  
    Positive predictive value 2.5 / 4.6 3.0 / 5.3  
At risk T2RF    
AUROC (95% CI) 0.881 (0.878 - 0.884) 0.860 (0.857 - 0.864) 0.021 (0.019 - 0.023)† 
Score ≥ 5 / Score ≥ 7    
    Sensitivity 78.5 / 57.6 73.2 / 51.8  
    Specificity 82.4 / 93.9 80.6 / 83.6  
    Positive predictive value 3.2 / 6.6 2.7 / 5.7  
Not at risk T2RF    
AUROC (95% CI) 0.910 (0.907 - 0.912) 0.891 (0.889 - 0.893) 0.019 (0.018 - 0.020)† 
Score ≥ 5 / Score ≥ 7    
    Sensitivity 72.0 / 51.7 73.5 / 54.5  
    Specificity 93.6 / 98.1 87.4 / 95.7  
    Positive predictive value 5.0 / 11.2 2.7 / 5.7  
 
 
Table 2. Performance metrics of the two scoring systems (NEWS and NEWS2) for predicting 
the primary outcome in the three risk groups, which include the area under the receiver 
operating characteristics curve (AUROC), with 95% confidence interval (CI), and sensitivity, 
specificity and positive predictive value values at a threshold of 5 and 7. The fourth column 
(NEWS – NEWS2) indicates the mean difference (95% CI) between the AUROCs of NEWS 
AC
CE
PT
ED
 M
AN
US
CR
IPT
28 
 
and NEWS2. T2RF denotes Type II Respiratory Failure. † Denotes significant difference in 
AUROC (p < 0.05). 
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TABLE 3 
 
 Documented T2RF At risk T2RF Not at risk T2RF 
Unanticipated ICU 
admission 
   
            NEWS 0.806 (0.786 - 0.826)* 0.814 (0.808 - 0.821) 0.841 (0.837 - 0.845) 
            NEWS2 0.816 (0.796 - 0.836)* 0.815 (0.808 - 0.821) 0.833 (0.829 - 0.837) 
            NEWS – NEWS2 -0.010 (-0.023 - 0.003)* 0.000 (-0.004 - 0.004) 0.008 (0.007 - 0.010)† 
Cardiac arrest    
             NEWS 0.701 (0.654 - 0.749)* 0.756 (0.744 - 0.769) 0.785 (0.776 - 0.794) 
             NEWS2 0.706 (0.658 - 0.753)* 0.741 (0.728 - 0.754) 0.768 (0.760 - 0.777) 
             NEWS – NEWS2 -0.004 (-0.046 - 0.037)* 0.015 (0.008 - 0.022)† 0.016 (0.012 - 0.020)† 
Composite outcome    
             NEWS 0.835 (0.824 - 0.847) 0.858 (0.855 - 0.861) 0.881 (0.879 - 0.884) 
             NEWS2 0.830 (0.818 - 0.841) 0.843 (0.840 - 0.847) 0.867 (0.864 - 0.869) 
             NEWS – NEWS2 0.006 (-0.003 - 0.014) 0.015 (0.013 - 0.016)† 0.015 (0.014 - 0.016)† 
 
Table 3. Performance metrics of the two scoring systems (NEWS and NEWS2) for predicting 
the secondary outcomes in the three risk groups: area under the receiver operating 
characteristics curve (AUROC), with 95% confidence interval (CI). NEWS –  NEWS2 indicates 
the mean difference (95% CI) between the AUROCs of NEWS and NEWS2. T2RF denotes 
Type II Respiratory Failure. * Where number of adverse outcomes is under 100. † Denotes 
significant difference in AUROC (p < 0.05). 
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